Price Chart

Profile

NovelStem International Corp focuses on the development and commercialization of diagnostic technology that can predict patients’ anti-cancer drug resistance, allowing for targeted cancer treatments and the potential to reduce resistance to chemotherapy.
URL https://www.novelstem.com
Investor Relations URL N/A
HQ State/Province Florida
Sector Health Care
Industry Biotechnology
Equity Style Small Cap/Blend
Next Earnings Release N/A
Last Earnings Release Oct. 29, 2014
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Apr. 02, 2018

Profile

NovelStem International Corp focuses on the development and commercialization of diagnostic technology that can predict patients’ anti-cancer drug resistance, allowing for targeted cancer treatments and the potential to reduce resistance to chemotherapy.
URL https://www.novelstem.com
Investor Relations URL N/A
HQ State/Province Florida
Sector Health Care
Industry Biotechnology
Equity Style Small Cap/Blend
Next Earnings Release N/A
Last Earnings Release Oct. 29, 2014
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Apr. 02, 2018